Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
Elizabeth ThieleEric MarshMaria Mazurkiewicz-BeldzinskaJonathan J HalfordBoudewijn GunningOrrin DevinskyDaniel CheckettsClaire RobertsPublished in: Epilepsia (2019)
In this study, long-term add-on CBD treatment had an acceptable safety profile in patients with LGS and led to sustained reductions in seizures.
Keyphrases